clinical trial · NCT07845630
A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body
HealthyVicadrostatEmpagliflozinVicadrostat + empagliflozin
brief summary
The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.
started
Oct 14, 2026
primary completion
Dec 11, 2026
completion
Dec 21, 2026
last updated
Oct 29, 2026
official title
Bioequivalence of Two Different Vicadrostat / Empagliflozin Formulations Following Oral Administration in Healthy Trial Participants (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol